1,544
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Development of gemcitabine-adsorbed magnetic gelatin nanoparticles for targeted drug delivery in lung cancer

, , , , &
Pages 943-949 | Received 17 Nov 2014, Accepted 18 Dec 2014, Published online: 23 Jan 2015

Figures & data

Figure 1. Sem image of M-GNPs.

Figure 1. Sem image of M-GNPs.

Table I. Effect of gemcitabine concentration, contact time, pH, and temperature on gemcitabine adsorption onto M-GNPs. M-GNP: Magnetic gelatin nanoparticle.

Figure 2. Langmuir isotherm curve of gemcitabine adsorption on nanoparticles.

Figure 2. Langmuir isotherm curve of gemcitabine adsorption on nanoparticles.

Table II. Langmuir isotherm constants for adsorption of gemcitabine by M-GNPs. M-GNP: Magnetic gelatin nanoparticle.

Table III. Thermodynamic constants for adsorption of gemcitabine by M-GNPs. M-GNP: Magnetic gelatin nanoparticle.

Figure 3. Pseudo-second order kinetic of gemcitabine adsorption on nanoparticles.

Figure 3. Pseudo-second order kinetic of gemcitabine adsorption on nanoparticles.

Figure 4. Intra-particle kinetic curve of gemcitabine adsorption on nanoparticles.

Figure 4. Intra-particle kinetic curve of gemcitabine adsorption on nanoparticles.

Table IV. Pseudo-second-order and intra-particle diffusion kinetic constants for adsorption of gemcitabine by M-GNPs. M-GNP: Magnetic gelatin nanoparticle.

Figure 5. Cumulative drug release of nanoparticles and free drug at pH 6 and pH 7.4.

Figure 5. Cumulative drug release of nanoparticles and free drug at pH 6 and pH 7.4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.